3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
2
Thrombocythemia, Essential
1
Stomatitis
1
Stomach Neoplasms
1
Radiation Pneumonitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Glioblastoma
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Breast Neoplasms
1
Attention Deficit Disorder with Hyperactivity
1
Acute Kidney Injury
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Acetylcysteine
×
1 year
×
Clear all
No trials found.